Orphenadrine Citrate Tablet, Extended Release
Product Images NDC 63187-122

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 63187-122). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

S:\ra\2011 Anda\orphenadrine Citrate Er Tablets\cbe (Labeling\Backup\062812\figure-01.jpg)

Chemical structure diagram showing two molecular structures side by side. The left structure includes a benzyl ring with methyl and ether-linked dimethylaminoethyl groups. The right structure depicts a citric acid molecule with three carboxyl groups and multiple hydroxyl groups. This image represents the chemical structures related to the active ingredient of MEDI-SULTING TOPICAL PAIN RELIEF 100 mg/1.*

FDA Label Image

122-30 (4ed1b591 Figure 02)

Label for MEDI-SULTING TOPICAL PAIN RELIEF containing Orphenadrine Citrate 100 mg extended-release tablets. The label indicates a quantity of 30 tablets, with tablets described as round and white to off-white, debossed with NL4 on one side. Packaged by Proficient Rx LP in Thousand Oaks, CA, with storage instructions and manufacturer noted as Novel Laboratories, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.